Excellence in oncology: Developing an effective biomarker strategy
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients. Payers are able to demonstrate that the treatment they are paying for will be of maximum value. Physicians feel confident that they are offering an effective drug, which is at the cutting-edge of medicine. And patients clearly benefit from a treatment programme that reduces the risk of unnecessary toxicities and offers them better outcomes.
Manufacturers with an innovator drug now in development will usually search for a suitable biomarker to launch alongside the drug. It is critical that manufacturers develop an effective launch/ marketing strategy for their biomarker in order to maximise uptake of their oncology brand.
We
are one of the largest independent healthcare market research and consulting
agencies in the world. Trusted partner to the global pharmaceutical industry,
we use our expertise and experience to deliver intelligent, tailor-made
solutions. We provide strategic recommendations that go beyond research,
helping our clients to answer their fundamental business challenges.
Register to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes. Research Partnership
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space. Research Partnership
Learn about a new behavioural science-led framework incorporating AI technologies that ensures you get a true reflection of how your communications materials are consumed and processed by customers Research Partnership